Frexalimab Has Favorable Effect on Relapsing Multiple Sclerosis
Generally favorable effect seen in terms of number of new gadolinium-enhancing T1-weighted lesions at week 12
Disparities Seen in Stroke Incidence for Indigenous, Non-Indigenous People
In countries with a very high Human Development Index, disparities are seen, although they vary
AI Can Predict Response to Early Sertraline for Chronic Major Depression
Findings based on neuroimaging and clinical data can speed knowledge of efficacy to one week
ASA: Adjuvant Methylprednisolone Role Examined in Acute Ischemic Stroke
No improvement seen in overall disability with methylprednisolone adjuvant to endovascular thrombectomy
ASA: Embolization of MMA Cuts Risk for Subsequent Subdural Hematoma, Surgery
Complications related to the embolization procedure low, and neurological function comparable with, without embolization
Insomnia Found to Be Common Among Nonhospitalized COVID-19 Survivors
Risk for insomnia even higher for those with depression or anxiety
Tobacco Use in Pregnancy Linked to Neurocognitive Deficits in Offspring
Lower scores seen on oral reading recognition, picture sequence memory, picture vocabulary tests at ages 9 to 12 years
ASA: Stroke Survivors Face Twofold Higher Risk for MI One Year After Stroke
Findings seen with or without cervical artery dissection
ASA: Nearly One in Five People Develop Dementia After Stroke
In the first year after stroke, there is an almost threefold higher risk for dementia
Lower Alzheimer Risk Seen With PDE5i Initiation for Erectile Dysfunction
Greatest reduction in risk seen for those receiving 21 to 50 phosphodiesterase type 5 inhibitor prescriptions
